We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

StageZero Life Sciences Ltd (SZLS) NPV

Sell:0.035 CAD Buy:0.045 CAD Change: No change
Market closed |  Prices as at close on 8 April 2024 | Switch to live prices |
Sell:0.035 CAD
Buy:0.045 CAD
Change: No change
Market closed |  Prices as at close on 8 April 2024 | Switch to live prices |
Sell:0.035 CAD
Buy:0.045 CAD
Change: No change
Market closed |  Prices as at close on 8 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

Contact details

Address:
30-70 East Beaver Creek Road
RICHMOND HILL
L4B 3B2
Canada
Telephone:
+1 (905) 2092030
Website:
https://www.stagezerolifesciences.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SZLS
ISIN:
CA8525403017
Market cap:
4.92 million CAD
Shares in issue:
123.53 million
Sector:
Biotechnology
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • James Howard-Tripp
    Chairman of the Board, Chief Executive Officer
  • Matthew Pietras
    Chief Financial Officer, Chief Operating Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.